Algo version: 0.98b
CERO is listed at the NASDAQ Exchange
CERO [CERO]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is CERO stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for CERo Therapeutics 10 years ago, but if you had invested on Tuesday 30th of November 2021 when the price was $9.93, you would have made a loss of $-9.68 per share or -97.49%

Yes, the average daily trading liquidity for CERo Therapeutics is $9.67 million. You should therefore be able to get in and out of your positions relatively fast.

CERo Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for CERo Therapeutics to be medium [0.6 out of 1]